Lantz Financial’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$624K Sell
7,229
-38
-0.5% -$3.35K 0.11% 158
2026
Q2
$568K Buy
7,267
+3,217
+79% +$260K 0.1% 165
2026
Q1
$351K Buy
4,050
+1,874
+86% +$180K 0.07% 196
2025
Q4
$209K Buy
+2,176
New +$211K 0.04% 243
2025
Q2
– Sell
-2,328
Closed -$209K – 240
2025
Q1
$209K Buy
+2,328
New +$208K 0.06% 208
2024
Q1
– Sell
-3,434
Closed -$283K – 210
2023
Q4
$283K Buy
3,434
+55
+2% +$4.19K 0.1% 164
2023
Q3
$265K Buy
3,379
+335
+11% +$28K 0.11% 155
2023
Q2
$268K Buy
3,044
+88
+3% +$7.58K 0.11% 159
2023
Q1
$238K Sell
2,956
-50
-2% -$4.08K 0.1% 164
2022
Q4
$234K Buy
+3,006
New +$244K 0.11% 159

Other funds holding MDT

Lantz Financial's MDT Position: Q3 2026 in Review

Lantz Financial reduced its Medtronic (MDT) stake by 0.52% in Q3 2026, selling an estimated $3.35K and leaving 7,229 shares worth $624K. The position accounts for 0.11% of the portfolio, ranked #158.

Lantz Financial first reported a position in MDT in Q4 2022 and has held it in 10 quarters since. 644 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Lantz Financial held 7,229 shares of Medtronic worth $624K as of Q3 2026.
  • Lantz Financial sold 38 Medtronic shares in Q3 2026, an estimated $3.35K.
  • Medtronic made up 0.11% of Lantz Financial's portfolio in Q3 2026, its #158 holding.
  • Lantz Financial first reported a position in Medtronic in Q4 2022 and has held it in 10 quarters since.
  • 644 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Lantz Financial's 13F filing for Q3 2026, filed 15 Oct 2026.